http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1161942-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21977e40c08969f3e950eb43ecafe0cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 1999-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a93ce243bc4c79fff97d28af65e3583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c56f17689ee0983b2fd5a06577aae747
publicationDate 2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1161942-A3
titleOfInvention Ophthalmic composition
abstract The ophthalmic compositions of this invention are used forntreatment of diabetic corneal lesion and/of for treatment ofndeteriorated corneal esthesia, which comprises, as an activeningredient, a compound represented by the general formula (I):n nwhereinn A and B are independently lower alkylene, X, Y, and Z are independently halogen, or a pharmacologically acceptable salt thereof. n In addition, the ophthalmic compositions of this invention arenused for treatment of non-diabetic corneal lesion, whichncomprise, as an active ingredient, an aldose reductase inhibitor. n The ophthalmic compositions of this invention are effective forntreatment of at least one disease selected among corneal lesionnand deteriorated corneal esthesia.
priorityDate 1998-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01125322-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0719767-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5582835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0218999-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0124327-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0170237-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411161974

Total number of triples: 26.